AGP
SLRN

Artia Global Partners’s ACELYRIN SLRN Stock Holding History

Artia Global Partners’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-93,114
Closed -$459K – 53
2024
Q3 		$459K Buy
+93,114
New +$481K 0.13% 42

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Artia Global Partners's SLRN Position: Q4 2024 in Review

Artia Global Partners sold out of ACELYRIN (SLRN) in Q4 2024, closing a stake of 93,114 shares — an estimated $459K sold.

Artia Global Partners first reported a position in SLRN in Q3 2024 and held it in 1 quarter. The position peaked at $459K in Q3 2024. 125 funds tracked by Wall St. Rank hold SLRN as of Q4 2024.

  • Artia Global Partners reported no remaining ACELYRIN position as of Q4 2024 after selling out during the quarter.
  • Artia Global Partners sold 93,114 ACELYRIN shares in Q4 2024, an estimated $459K.
  • Artia Global Partners first reported a position in ACELYRIN in Q3 2024 and held it in 1 quarter.
  • Artia Global Partners's ACELYRIN position peaked at $459K in Q3 2024.
  • 125 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2024.

Based on Artia Global Partners's 13F filing for Q4 2024, filed 14 Feb 2025.